Several studies highlighted NK cell ability to recognize and kill poorly differentiated tumors [138,139,140] and that cytokine-activated (IL2 and/or IL15-activated) NK cells were effective against human breast, colon, melanoma and glioblastoma CSCs [141,142,143]. The gene discussed is IL2; the disease is glioblastoma.